0001209191-21-070938.txt : 20211222
0001209191-21-070938.hdr.sgml : 20211222
20211222165309
ACCESSION NUMBER: 0001209191-21-070938
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20211221
FILED AS OF DATE: 20211222
DATE AS OF CHANGE: 20211222
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Mylet Johanna
CENTRAL INDEX KEY: 0001765988
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39376
FILM NUMBER: 211513858
MAIL ADDRESS:
STREET 1: C/O POSEIDA THERAPEUTICS, INC.
STREET 2: 4242 CAMPUS POINT COURT, SUITE 700
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Poseida Therapeutics, Inc.
CENTRAL INDEX KEY: 0001661460
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 472846548
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 9390 TOWNE CENTRE DRIVE
STREET 2: SUITE 200
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
BUSINESS PHONE: 858-779-3100
MAIL ADDRESS:
STREET 1: 9390 TOWNE CENTRE DRIVE
STREET 2: SUITE 200
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2021-12-21
0
0001661460
Poseida Therapeutics, Inc.
PSTX
0001765988
Mylet Johanna
C/O POSEIDA THERAPEUTICS, INC.
9390 TOWNE CENTRE DRIVE, STE 200
SAN DIEGO
CA
92121
0
1
0
0
Chief Financial Officer
Common Stock
2021-12-21
4
M
0
2616
1.173
A
31131
D
Common Stock
2021-12-21
4
M
0
3100
1.933
A
34231
D
Stock Option (Right to Buy)
1.173
2021-12-21
4
M
0
2616
0.00
D
2026-02-28
Common Stock
2616
0
D
Stock Option (Right to Buy)
1.933
2021-12-21
4
M
0
3100
0.00
D
2028-02-05
Common Stock
3100
3816
D
The stock option is fully vested and exercisable.
12.5% of the shares shares subject to the stock option vested and became exercisable on August 6, 2018, and the remaining shares vest in 42 equal monthly installments thereafter.
/s/ Harry J. Leonhardt, Attorney-in-Fact
2021-12-22